Results 51 to 60 of about 5,213 (101)

[Research advances of magnetic resonance elastography for assessing the bioinvasiveness in hepatocellular carcinoma]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Ma MY, Li RK.
europepmc   +1 more source

[<i>MUTYH-APEX1</i> Axis Promotes Hepatocellular Carcinoma Progression and Therapeutic Resistance by Regulating Cell Cycle Proteins]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban
Zhou Y, Zhang H, Zhu Y, Jiang P, Feng T, Wu Z, Chen J.   +6 more
europepmc   +1 more source

[Research progress on poor response, resistance mechanisms, and influencing factors of immunotherapy for hepatocellular carcinoma]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Huang M, Zhang FN, Gong H, Liu CC, Zhao TT, He N.   +5 more
europepmc   +1 more source

[Heterogeneity of tumor-associated macrophages and precision targeting strategies in hepatocellular carcinoma]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Huang K, Zhang GQ.
europepmc   +1 more source

刘晓平 　区庆嘉 　黄洪莲　王小宁

Zhongshan Daxue xuebao. Yixue kexue ban, 1998
目的: 研究小鼠 B7 基因转染对小鼠肝癌细胞 Hepal-6 细胞株细胞形态、生长速度及致瘤性的影响。方法: 用逆转录病毒载体,将 小鼠B7 基因导入小鼠肝癌细胞 Hepal-6 细胞株中,经G418 筛选,获得高表达 B7分子的阳性细胞克隆,采用CTLA-4Ig 的间接免疫荧光法检测 B7 分子的表达情况,并观察了B7 基因转染对细胞形态、生长速度及致瘤性的影响。结果:①亲本小鼠肝癌细胞株 Hepal-6 不表达 B7 分子,转 染 B7 基因的 Hepal-6 细胞高表达 B7 分子;②转染 B7
doaj  

[Exploration and application of nanotechnology in precision transarterial chemoembolization for hepatocellular carcinoma]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Kong JQ, Li R, Zuo RN, Zhang X, Ding ZH, Dai Y.   +5 more
europepmc   +1 more source

[Chinese expert consensus on the use of standardized second-line drugs for primary hepatocellular carcinoma]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Translational Medicine Branch, China Association of Gerontology and Geriatrics, Society of Hepatology, Beijing Medical Association, Expert Committee on Liver Cancer, Chinese Society of Clinical Oncology.   +5 more
europepmc   +1 more source

[High expression of MPP6 predicts poor patient prognosis and promotes malignant biological behaviors of hepatocellular carcinoma cells]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Yu H, Shao Y, Cheng Q, Zhou X, Geng H, Yang Y.   +5 more
europepmc   +1 more source

[Research progress in the extent of hepatocellular carcinoma in the year 2024]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Nan YM, Miao TG, Zhao SX.
europepmc   +1 more source

[Emphasis on targeted and immunotherapy for liver injury in hepatocellular carcinoma]. [PDF]

Zhonghua Gan Zang Bing Za Zhi, 2023
Nan YM, Liu LD, Zhao SX.
europepmc   +1 more source